Searched for
ALKEM LABS SHARES
Alkem Labs shares in focus as Goldman, Morgan Stanley, others purchase stake in Rs 930-crore block dealShares of Alkem Laboratories will be in focus after block deals worth around Rs 930 crore saw 17.88 lakh shares traded at Rs 5,200 apiece o...- Stocks in news: Alkem Labs, Vedanta, Canara Bank, NHPC, Adani PortsMarkets closed higher on weekly expiry day despite volatility, with Nifty showing signs of recovery but facing resistance around 23,800-24,...
- Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAlkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- Small & midcaps rally! Wockhardt, Coforge, other stocks surge up to 14%. Do you own any?Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Stocks in news: Infosys, Trent, Jio Financial, Hindustan Copper, Adani EnergyMarkets experienced a corrective session, with Nifty expected to consolidate but maintain a positive bias. Key stocks like Infosys, Trent, ...
- Alkem Labs CEO Vikas Gupta may exit companyAlkem Labs, a leading Indian drug maker, is set for a top management change. Vikas Gupta, the CEO for nearly three years, is expected to de...
- Alkem Labs Q1 Results: Net profit zooms 90% to Rs 545 croreThe company reported Rs 287 crore in the corresponding quarter of the previous year. Revenue from operations grew 2.2% y-o-y to Rs 3032 cro...
- Alkem Labs plunges more than 13%, sees biggest single-day fall in over 3 years on tax evasion allegationIn September last year, the tax department conducted surveys on the offices and premises of the company after receiving intelligence regard...
- Buy Alkem Laboratories, target price Rs 3500: Motilal OswalAlkem Laboratories Ltd., incorporated in the year 1973, is a Large Cap company (having a market cap of Rs 35273.47 Crore) operating in Phar...
- Buy Alkem Lab, target price Rs 3,300: Angel BrokingThe pharma company is expected to outperform the Indian Pharmaceutical market (IPM) by 1.5 times growth rate for the next 2 years.
- Buy Alkem Laboratories, target price Rs 3,300: Angel BrokingThe company is expected to outperform the Indian Pharmaceutical market (IPM) by 1.5 times growth rate for the next two years.
- Buy Alkem Laboratories, target price Rs 2,700: Motilal OswalThe evolving situation due to the Covid-19 outbreak is likely to have a mixed impact on the domestic formulation (DF) growth outlook over t...
- Buy Alkem Laboratories, target Rs 2,340: HDFC SecuritiesBuy Alkem Laboratories at a price target of Rs 2,340.
- Buy Alkem Laboratories, target Rs 2,307: Anand RathiBuy Alkem Laboratories at a price target of Rs 2307.
- Alkem stock up 5% as its Gujarat unit gets USFDA nodShares of Alkem Labs today went up by over 5 per cent after the company said one of its manufacturing plants in Gujarat has obtained establ...
- Alkem Labs, Dr Lal PathLabs listings to help drive expansionAlkem Labs and Dr Lal PathLabs made an impressive start at the bourses on Wednesday, opening 31 per cent and 50 per cent higher from their ...
- 2015: Best year for IPOs since 2010; Dr Lal surges 50%, Alkem gains 31% on street debutOn Dr Lal PathLabs, Bansal said valuation of the company appears expensive after the strong listing and investors should wait for the compa...
- Alkem, Dr Lal PathLabs to make stock market debut on December 23Dr Lal's IPO too was a huge success with 33.41 times oversubscription. The price band was fixed at Rs 540-550 per share for the Rs 638 cror...
Load More
